Thyroid C-cell Tumors: In rodent reports, semaglutide is demonstrated to induce thyroid C-mobile tumors. It's unidentified whether this hazard relates to humans, but semaglutide is contraindicated in people with a personal or household historical past of medullary thyroid carcinoma (MTC) or clients with Multiple Endocrine Neoplasia syndrome form 2